Home › NDC Lookup › RxCUI directory › RxCUI 309888

Digoxin 0.125 MG Oral Tablet [Lanoxin] — RxCUI 309888

RxNorm drug concept · Semantic branded drug
RxCUI 309888 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI309888
Official nameDigoxin 0.125 MG Oral Tablet [Lanoxin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLanoxin 125 MCG Oral Tablet; Lanoxin 0.125 MG Oral Tablet
FDA products mapped4
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Digoxin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Digoxin is being used for one of two main reasons: either to help your heart pump more effectively in heart failure, or to slow down a fast heart rate caused by atrial fibrillation...
  • Why did my doctor prescribe digoxin — what is it actually doing for me?
  • The most important ones to call your doctor about are nausea, vomiting, loss of appetite, unusual vision changes (like seeing a yellow-green tint or halos around lights), dizziness...
  • What side effects should I actually watch out for?
📖 Read our full Digoxin guide →

🕸️ Concept Web — How Digoxin 0.125 MG Oral Tablet [Lanoxin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Digoxin 0.125 MG Oral Tablet [Lanoxin] RxCUI 309888

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Digoxin 3407
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lanoxin 202988
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Digoxin Oral Tablet 371834
    • Digoxin Oral Product 1151521
    • Digoxin Pill 1151522
    • Digoxin Oral Tablet [Lanoxin] 367682
    • Lanoxin Oral Product 1175615
    • Lanoxin Pill 1175618
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Digoxin 0.125 MG Oral Tablet SCD · 197604
  • Digoxin 0.125 MG SCDC · 315819
  • Digoxin Oral Tablet SCDF · 371834
  • Digoxin Oral Product SCDG · 1151521
  • Digoxin Pill SCDG · 1151522

Brand-Name Concepts

  • Digoxin 0.125 MG [Lanoxin] SBDC · 575108
  • Digoxin Oral Tablet [Lanoxin] SBDF · 367682
  • Lanoxin Oral Product SBDG · 1175615
  • Lanoxin Pill SBDG · 1175618
  • Lanoxin BN · 202988

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 309888 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59212-0240-55 100 TABLET in 1 BOTTLE (59212-240-55) LANOXIN Advanz Pharma (US) Corp. 2012-09-30
59212-0242-55 100 TABLET in 1 BOTTLE (59212-242-55) LANOXIN Advanz Pharma (US) Corp. 2012-09-30
59212-0242-56 10 BLISTER PACK in 1 CARTON (59212-242-56) / 10 TABLET in 1... LANOXIN Advanz Pharma (US) Corp. 2012-09-30
59212-0249-55 100 TABLET in 1 BOTTLE (59212-249-55) LANOXIN Advanz Pharma (US) Corp. 2012-09-30
71610-0019-60 90 TABLET in 1 BOTTLE (71610-019-60) LANOXIN Aphena Pharma Solutions - Tennessee, LLC 2017-12-08
Observed labelers: Advanz Pharma (US) Corp. (4) · Aphena Pharma Solutions - Tennessee, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.